Open AccessThe effect of eradication therapy on the quality of life of patients with chronic erosive gastritis induced with Helicobacter pylori
Author(s) -
Т. Е. Афанасенкова,
Е. Е. Дубская
Publication year - 2021
Publication title -
èksperimentalʹnaâ i kliničeskaâ gastroènterologiâ
Language(s) - English
Resource type - Journals
ISSN - 1682-8658
DOI - 10.31146/1682-8658-ecg-193-9-53-59
Subject(s) - medicine , dispensary , exacerbation , helicobacter pylori , gastritis , quality of life (healthcare) , gastroenterology , chronic gastritis , disease , helicobacter , pathology , nursing
The aim of the study was to evaluate the effect of eradication therapy on the quality of life of patients with chronic erosive gastritis induced with Helicobacter pylori. The quality of life was assessed according to the GIQLI questionnaire before treatment during incomplete remission, remission, and during the year. It was found that the exacerbation of the disease significantly changes the level of quality of life of patients, and the complex treatment, eradication of Helicobacter pylori, which stopped the exacerbation of the disease, gradually increases and brings this indicator closer to the control group. The gastrointestinal quality of life index can be used as an additional criterion for diagnosing the stages of chronic erosive gastritis, for evaluating the effectiveness of therapy, determining the timing of treatment, rehabilitation and prevention in the dispensary management of patients at the therapeutic site.